低分子肝素钠联合酚妥拉明治疗肺心病心衰30例临床分析

Low Molecular Heparin Plus Phentolamine for Pneumocardial Disease:An Analysis of 60 Cases

目的观察低分子肝素钠与酚妥拉明治疗肺源性心脏病(简称肺心病)心力衰竭的疗效。方法将60例病人随机分为治疗组与对照组,对照组给予常规吸氧、抗炎、祛痰、平喘、纠正水电解质和酸碱平衡紊乱,适当强心、利尿及治疗原发病。治疗组在对照组治疗基础上加用低分子肝素钠与酚妥拉明治疗7d。结果治疗组总有效率90%,对照组为66.7%,两组比较有显著性差异(P<0.05)。结论低分子肝素钠与酚妥拉明合用治疗肺心病心力衰竭有良好的疗效。

Objective To observe the curative effect of low molecular heparin plus phentolamine in the treatment of heart failure in pneumoeardial disease. Methods Sixty cases of pneumoeardial disease were randomly divided into treatment group and control group. Both groups were given eonventional treatment including oxygen uptake, anti-inflammatory agent, expectorant, antiasthmatie drug, correction of water-electrolyte and acid-base imbalance, adequate cardiac, diuretic and treatment of primary disease, and low molecular heparin plus phentolamine was added to the treatment group for 7 days. Results The total efficiency of the treatment group was 90% and that of the control group was 66.7%,with a significant difference between the two groups（P〈0.05 ）. Conclusion Low molecular heparin and phentolamine in the combined treatment of heart failure in pneumocardial disease have a good effect.